Response to the letter 'Conservative Handling of Cluster Randomized Trials'.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Works matching IS 17407745 AND DT 2012 AND VI 9 AND IP 3
Results: 16
1
2
Considerations in the paper by Proschan, Brittain, and Kammerman are not an argument against minimization. In response to Vance W Berger 'Minimization: not all it's cracked up to be', Clin Trials 2011; 8: 443.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
3
Clinical Trial Educator program - a novel approach to accelerate enrollment in a phase III International Acute Coronary Syndrome Trial.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
4
Response to the letter ‘Conservative Handling of Cluster Randomized Trials’.
- Published in:
- Clinical Trials, 2012, v. 9, n. 3, p. 372, doi. 10.1177/1740774512444638
- By:
- Publication type:
- Article
5
Considerations in the paper by Proschan, Brittain, and Kammerman are not an argument against minimization. In response to Vance W Berger ‘Minimization: not all it’s cracked up to be’, Clin Trials 2011; 8: 443.
- Published in:
- Clinical Trials, 2012, v. 9, n. 3, p. 370, doi. 10.1177/1740774512444637
- By:
- Publication type:
- Article
6
Conservative handling of cluster randomized trials.
- Published in:
- Clinical Trials, 2012, v. 9, n. 3, p. 371, doi. 10.1177/1740774512444177
- By:
- Publication type:
- Article
7
Establishing HIV treatment as prevention in the HIV Prevention Trials Network 052 randomized trial: an ethical odyssey.
- Published in:
- Clinical Trials, 2012, v. 9, n. 3, p. 340, doi. 10.1177/1740774512443594
- By:
- Publication type:
- Article
8
Dose-finding clinical trial design for ordinal toxicity grades using the continuation ratio model: an extension of the continual reassessment method.
- Published in:
- Clinical Trials, 2012, v. 9, n. 3, p. 303, doi. 10.1177/1740774512443593
- By:
- Publication type:
- Article
9
Taking the long view: how to design a series of Phase III trials to maximize cumulative therapeutic benefit.
- Published in:
- Clinical Trials, 2012, v. 9, n. 3, p. 283, doi. 10.1177/1740774512443430
- By:
- Publication type:
- Article
10
A Bayesian approach for unplanned sample sizes in phase II cancer clinical trials.
- Published in:
- Clinical Trials, 2012, v. 9, n. 3, p. 293, doi. 10.1177/1740774512443429
- By:
- Publication type:
- Article
11
Clinical Trial Educator program – a novel approach to accelerate enrollment in a phase III International Acute Coronary Syndrome Trial.
- Published in:
- Clinical Trials, 2012, v. 9, n. 3, p. 358, doi. 10.1177/1740774512440760
- By:
- Publication type:
- Article
12
Temporal compliance trends in a cluster randomization with crossover trial of out-of-hospital cardiac arrest.
- Published in:
- Clinical Trials, 2012, v. 9, n. 3, p. 314, doi. 10.1177/1740774512440636
- By:
- Publication type:
- Article
13
An adaptive strategy for assessing regional consistency in multiregional clinical trials.
- Published in:
- Clinical Trials, 2012, v. 9, n. 3, p. 330, doi. 10.1177/1740774512440635
- By:
- Publication type:
- Article
14
Clinician-trialist rounds: 10. Mentoring – part 4: attributes of an effective mentor.
- Published in:
- Clinical Trials, 2012, v. 9, n. 3, p. 367, doi. 10.1177/1740774512440343
- By:
- Publication type:
- Article
15
Motivations of patients with pulmonary arterial hypertension to participate in randomized clinical trials.
- Published in:
- Clinical Trials, 2012, v. 9, n. 3, p. 348, doi. 10.1177/1740774512438981
- By:
- Publication type:
- Article
16
National Institute of Neurological Disorders and Stroke Common Data Element Project – approach and methods.
- Published in:
- Clinical Trials, 2012, v. 9, n. 3, p. 322, doi. 10.1177/1740774512438980
- By:
- Publication type:
- Article